Teriparatide (forteo)    (DrugBank: Teriparatide)

1 disease
IDDisease name (Link within this page)Number of trials
274Osteogenesis Imperfecta1

274. Osteogenesis Imperfecta    [ 78 clinical trials,   87 drugs,   (DrugBank: 19 drugs),   14 drug target genes,   74 drug target pathways]
Searched query = "Osteogenesis Imperfecta"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 78 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00131469
(ClinicalTrials.gov)
June 200516/8/2005Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis ImperfectaA Study to Assess the Effectiveness of Teriparatide (FORTEO) for Increasing Bone Mass and Improving Bone Strength in Adults Affected With Osteogenesis Imperfecta (OI)Osteogenesis ImperfectaDrug: Teriparatide (FORTEO);Drug: PlacebosOregon Health and Science UniversityEli Lilly and Company;Osteogenesis Imperfecta Foundation;National Institutes of Health (NIH);National Center for Research Resources (NCRR)Completed18 Years85 YearsAll79Phase 4United States